Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  ACS Nano

• Publication date

  2009-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/nn8008504PMID 19226129PMCID PMC2707358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting vault nanoparticles to specific cell surface receptors.

  2009cited by this paper
• Sizing large proteins and protein complexes by electrospray ionization mass spectrometry and ion mobility

  2007cited by this paper
• Vault nanocapsule dissociation into halves triggered at low pH.

  2007cited by this paper
• Draft Crystal Structure of the Vault Shell at 9-Å Resolution

  2007cited by this paper
• Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells

  2007cited by this paper
• Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates.

  2007cited by this paper
• In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes.

  2007cited by this paper
• Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells

  2007cited by this paper
• Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.

  2007cited by this paper
• Current status of polymeric gene delivery systems.

  2006cited by this paper
• Cationic lipids, lipoplexes and intracellular delivery of genes.

  2006cited by this paper
• The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.

  2006cited by this paper
• Gene transfer in humans using a conditionally replicating lentiviral vector

  2006cited by this paper
• Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin.

  2006cited by this paper
• Engineering of vault nanocapsules with enzymatic and fluorescent properties.

  2005cited by this paper
• Adenovirus Protein VI Mediates Membrane Disruption following Capsid Disassembly

  2005cited by this paper
• Adenoviruses as vaccine vectors

  2004cited by this paper
• Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.

  2004cited by this paper
• Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture.

  2004cited by this paper
• Identification of Adenovirus (Ad) Penton Base Neutralizing Epitopes by Use of Sera from Patients Who Had Received Conditionally Replicative Ad (Addl1520) for Treatment of Liver Tumors

  2003cited by this paper
• Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA)

  2003cited by this paper
• The Role of Organ Vascularization and Lipoplex-Serum Initial Contact in Intravenous Murine Lipofection*

  2003cited by this paper
• Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

  2001cited by this paper
• Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein*

  2001cited by this paper
• Calcium phosphate precipitates augment adenovirus-mediated gene transfer to blood vessels in vitro and in vivo

  2000cited by this paper
• The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase

  1999cited by this paper
• Mechanism by which calcium phosphate coprecipitation enhances adenovirus-mediated gene transfer

  1999cited by this paper
• Delivery of an Adenovirus Vector in a Calcium Phosphate Coprecipitate Enhances the Therapeutic Index of Gene Transfer to Airway Epithelia

  1999cited by this paper
• The drug resistance-related protein LRP is the human major vault protein

  1995cited by this paper
• Ribosome-inactivating proteins from plants.

  1993cited by this paper
• Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry

  1991influential reference
• Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes

  1990cited by this paper
• The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation.

  1987cited by this paper
• pH-dependent lysis of liposomes by adenovirus.

  1986cited by this paper
• Tobacco rattle virus RNA-protein interactions.

  1976cited by this paper
• Assembly of flexuous plant viruses and their proteins.

  1976cited by this paper

• Integrin-Targeting Strategies for Adenovirus Gene Therapy

  2024cites this paper
• Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy’s neutralizing antibody problem

  2024cites this paper
• Manufacturing of non-viral protein nanocages for biotechnological and biomedical applications

  2023cites this paper
• Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects

  2023cites this paper
• All-in-one biofabrication and loading of recombinant vaults in human cells

  2022cites this paper
• Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol

  2022cites this paper
• The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy

  2021cites this paper
• Adenovirus - a blueprint for gene delivery.

  2021cites this paper
• Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma

  2020cites this paper
• The practical self-targeted oncolytic adenoviral nanosphere based on immuno-obstruction method via polyprotein surface precipitation technique enhances transfection efficiency for virotherapy.

  2019cites this paper
• A protein nanocontainer targeting epithelial cancers: rational engineering, biochemical characterization, drug loading and cell delivery.

  2019cites this paper
• Synthesis and assembly of human vault particles in yeast

  2018cites this paper
• Nanotechnology for Synthetic Biology: Crossroads Throughout Spatial Confinement

  2017cites this paper
• Polypeptides and Engineered Proteins

  2017cites this paper
• Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery.

  2017cites this paper
• Bioengineered protein-based nanocage for drug delivery.

  2016cites this paper
• Decrease in pH destabilizes individual vault nanocages by weakening the inter-protein lateral interaction

  2016cites this paper
• Vault Nanoparticles Packaged with Enzymes as an Efficient Pollutant Biodegradation Technology.

  2015cites this paper
• Protein nanoparticles for therapeutic protein delivery.

  2015cites this paper
• Peroxidase Enzymes Packaged in Vaults as an Innovative Bioremediation Technology

  2015cites this paper
• Virus‐Surface‐Mimicking Surface Clustering of AuNPs onto DNA‐Entrapped Polymeric Nanoparticle for Enhanced Cellular Internalization and Nanocluster‐Induced NIR Photothermal Therapy

  2015cites this paper
• Stepwise-acid-active multifunctional mesoporous silica nanoparticles for tumor-specific nucleus-targeted drug delivery.

  2014cites this paper
• The role of adenoviral capsid protein VI in cell cycle modulation

  2014cites this paper
• Can controversial nanotechnology promise drug delivery?

  2013cites this paper
• Diving through Membranes: Molecular Cunning to Enforce the Endosomal Escape of Antibody-Targeted Anti-Tumor Toxins

  2013cites this paper
• Peptide and Protein-Based Nanoparticles

  2013cites this paper
• Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.

  2013cites this paper
• Development of the vault particle as a platform technology.

  2013cites this paper
• Engineered mutations change the structure and stability of a virus-like particle.

  2012cites this paper
• Spatial organization of enzymes for metabolic engineering.

  2012cites this paper
• Endogenous Vaults and Bioengineered Vault Nanoparticles for Treatment of Glioblastomas for Future Targeted Therapies

  2012cites this paper
• Structural Dynamics of the Vault Ribonucleoprotein Particle

  2012cites this paper
• Multistage pH‐Responsive Liposomes for Mitochondrial‐Targeted Anticancer Drug Delivery

  2012cites this paper
• Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies.

  2012cites this paper
• Vault particles: a new generation of delivery nanodevices.

  2012cites this paper
• Reactions inside nanoscale protein cages.

  2011cites this paper
• Functional Genetic and Biophysical Analyses of Membrane Disruption by Human Adenovirus

  2011cites this paper
• Hydrophobic polyphenylalanine-grafted hyperbranched polyethylenimine and its in vitro gene transfection.

  2011cites this paper
• Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.

  2011influential citation
• Human Adenovirus Analyses of Membrane Disruption by Functional Genetic and Biophysical

  2011cites this paper
• Vaults engineered for hydrophobic drug delivery.

  2011cites this paper
• Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth

  2011influential citation
• Applications of viral nanoparticles in medicine.

  2011cites this paper
• Nanopediatrics: Enabling Personalized Medicine for Children

  2010cites this paper
• Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.

  2010cites this paper